All Bristol-Myers Squibb articles – Page 2

Business
Bristol-Myers Squibb fined for alleged Chinese bribes

2015-10-07T00:00:00Z

US Securities and Exchange Commission accepts $14m settlement for charges covering the last five years
Feature
Pharma queues up for checkpoint inhibitor collaborations

2015-07-03T00:00:00Z

Combinations of different firms’ drugs seek to reap immuno-oncology’s benefits
Business
BMS sues executive for joining rival company

2015-06-05T00:00:00Z

Bristol-Myers Squibb’s lawsuit against its former immuno-oncology chief who left to work for AstraZeneca has implications for biopharma industry
Business
BMS invests in gene therapy

2015-04-09T00:00:00Z

Bristol-Myers Squibb makes $100 million deal with biotech uniQure
Business
BMS bolsters immuno-oncology with pair of deals

2015-02-24T00:00:00Z

Firm will acquire Flexus Biosciences and collaborate with Rigel
Business
Riding new waves

2015-01-06T00:00:00Z

Pharmaceutical industry roundup of 2014
Business
Clinical collaborations drive cancer immunotherapy

2014-08-27T00:00:00Z

Companies race to pair up chemotherapy drugs with immune system-boosting antibodies to greatest effect in trials
Business
First of a new breed of anticancer antibodies approved in Japan

2014-07-08T00:00:00Z

Ono claims Opdivo is the first anti-PD1 treatment in the world
Business
EMA wrangles restrain trial data progress

2014-07-03T00:00:00Z

Attempts to balance industry and research interests on transparency draw suggestions of improper collusion
Business
Pharma vies to unleash immune system power on cancer

2014-06-12T00:00:00Z

Immuno-oncological drugs look set to earn billions and significantly lengthen patients’ lives
Business
Bristol-Myers Squibb to close Irish plant

2014-03-14T00:00:00Z

130 jobs to go at manufacturing site in Cruiserath
Business
AstraZeneca shells out $4.1bn for diabetes business

2013-12-20T00:00:00Z

Bristol-Myers Squibb exits the diabetes field with plans to become a specialised biopharmaceutical company
Business
New wave of hepatitis C drugs hits US shore

2013-12-03T00:00:00Z

J&J’s once-daily drug approved by FDA, but rivals are hot on its heels
News
Chemist sentenced to life

2013-10-03T00:00:00Z

Tianle Li, who poisoned her husband with thallium, has been sentenced to life imprisonment
News
Chemist found guilty of murder

2013-07-17T00:00:00Z

Tianle Li poisoned her husband with thallium obtained from the lab where she worked
Feature
From molecules to medicines

2013-04-09T00:00:00Z

Turning an active drug molecule into a finished product requires as much chemistry as developing the drug in the first place, as Phillip Broadwith discovers
Business
Amylin headquarters to close with further job losses

2013-04-04T00:00:00Z

Bristol-Myers Squibb plans to shutter the San Diego, US, site following last year’s merger
Business
BMS sells OTC drugs for $482m

2013-02-14T00:00:00Z

Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser
Business
India pushes for emergency drug licences

2013-01-21T00:00:00Z

Government looks set to force licensing of three patented cancer drugs
Business
Patent woes lead to sharp sales losses

2012-10-26T00:00:00Z

Bristol-Myers Squibb, AstraZeneca and Eli Lilly have all suffered loss of exclusivity for key drugs